Stig Linder

8.9k total citations
151 papers, 7.1k citations indexed

About

Stig Linder is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Stig Linder has authored 151 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 51 papers in Oncology and 31 papers in Cell Biology. Recurrent topics in Stig Linder's work include Ubiquitin and proteasome pathways (42 papers), Cell death mechanisms and regulation (24 papers) and Cancer-related Molecular Pathways (21 papers). Stig Linder is often cited by papers focused on Ubiquitin and proteasome pathways (42 papers), Cell death mechanisms and regulation (24 papers) and Cancer-related Molecular Pathways (21 papers). Stig Linder collaborates with scholars based in Sweden, United States and Germany. Stig Linder's co-authors include Maria C. Shoshan, Pádraig D’Arcy, Maria Hägg Olofsson, Aleksandra Mandic, Johan Hansson, Xiaonan Zhang, Rolf Larsson, Mårten Fryknäs, Aleksandra Mandic Havelka and Takayuki Ueno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Stig Linder

149 papers receiving 7.0k citations

Peers

Countries citing papers authored by Stig Linder

Since Specialization

Citations

This map shows the geographic impact of Stig Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stig Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stig Linder more than expected).

Fields of papers citing papers by Stig Linder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stig Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stig Linder. The network helps show where Stig Linder may publish in the future.

Co-authorship network of co-authors of Stig Linder

This figure shows the co-authorship network connecting the top 25 collaborators of Stig Linder. A scholar is included among the top collaborators of Stig Linder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stig Linder. Stig Linder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of point-of-care tests for urinary bladder cancer – an historic review and view to future prospectives 2025 ·Urologic Oncology Seminars and Original Investigations ·Thorsten Ecke, Johan Styrke, Kiran Jagarlamudi, Stig Linder	1
2	Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System 2021 ·Biomolecules ·Karthik Selvaraju, Kourosh Lotfi, (unknown), (unknown), (unknown), (unknown), Lasse D. Jensen, Stig Linder, Pádraig D’Arcy	2
3	Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570 2020 ·International Journal of Molecular Sciences ·Paola Pellegrini, Karthik Selvaraju, (unknown), (unknown), Xiaonan Zhang, (unknown), (unknown), Stig Linder, Pádraig D’Arcy	13
4	Dienone Compounds: Targets and Pharmacological Responses 2020 ·Journal of Medicinal Chemistry ·Martina Bazzaro, Stig Linder	12
5	Identification of proteasome inhibitors using analysis of gene expression profiles 2020 ·European Journal of Pharmacology ·(unknown), Karthik Selvaraju, (unknown), Pádraig D’Arcy, Stig Linder	15
6	Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer 2019 ·International Journal of Molecular Sciences ·(unknown), Sally A. Mullany, Zenas Chang, Charles N. Landen, Stig Linder, Martina Bazzaro	87
7	Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug 2019 ·Biochimie ·Xiaonan Zhang, Karthik Selvaraju, Amir Ata Saei, Pádraig D’Arcy, Roman A. Zubarev, Elias S.J. Arnér, Stig Linder	131
8	Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment 2019 ·Oxidative Medicine and Cellular Longevity ·Xiaonan Zhang, Belén Espinosa, Amir Ata Saei, Pádraig D’Arcy, Roman A. Zubarev, Stig Linder	13
9	Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15 2019 ·PLoS ONE ·(unknown), Paola Perego, Karthik Selvaraju, Laura Gatti, Joachim Gullbo, Stig Linder, Pádraig D’Arcy	10
10	Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy 2018 ·Science Translational Medicine ·William C. Stafford, Xiaoxiao Peng, Maria Hägg Olofsson, Xiaonan Zhang, Diane K. Luci, Frank Leigh Lu, Qing Cheng, L. Tresaugues, Thomas S. Dexheimer, Nathan P. Coussens, Martin Augsten, (unknown), Owe Orwar, Arne Östman, Sharon Stone‐Elander, David J. Maloney, Ajit Jadhav, Anton Simeonov, Stig Linder, Elias S.J. Arnér	164
11	The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells 2016 ·Scientific Reports ·Xin Wang, Magdalena Mazurkiewicz, Ellin‐Kristina Hillert, Maria Hägg Olofsson, Stefan Pierrou, (unknown), Joachim Gullbo, Karthik Selvaraju, Aneel Paulus, Sharoon Akhtar, Felicitas Bossler, Asher Khan, Stig Linder, Pádraig D’Arcy	133
12	Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics 2016 ·Trends in cancer ·Xiaonan Zhang, Angelo De Milito, (unknown), Joachim Gullbo, Pádraig D’Arcy, Stig Linder	16
13	Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer 2015 ·Molecular Cancer Therapeutics ·Wojciech Senkowski, Xiaonan Zhang, Maria Hägg Olofsson, Ruben Isacson, Urban Höglund, Mats Gustafsson, Peter Nygren, Stig Linder, Rolf Larsson, Mårten Fryknäs	118
14	Keratin‐18 and micro RNA ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts 2013 ·Liver International ·Petra Thulin, Gunnar Nordahl, Marcus Gry, Getnet Yimer, Eleni Aklillu, Eyasu Makonnen, Getachew Aderaye, Lars Lindquist, C. Mikael Mattsson, Björn Ekblom, Daniel J. Antoine, (unknown), Stig Linder, Alison H. Harrill, Paul B. Watkins, Björn Glinghammar, Ina Schuppe‐Koistinen	89
15	Autophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress 2012 ·Journal of Biological Chemistry ·Maria Lucia Marino, Paola Pellegrini, Giuseppe Di Lernia, Mojgan Djavaheri‐Mergny, Slavica Brnjic, Xiaonan Zhang, Maria Hägg, Stig Linder, Stefano Fais, Patrice Codogno, Angelo De Milito	144
16	Chemical biology suggests a role for calcium signaling in mediating sustained JNKactivation during apoptosis 2010 ·Molecular BioSystems ·Slavica Brnjic, Maria Hägg Olofsson, Aleksandra Mandic Havelka, Stig Linder	34
17	Increased apoptosis and increased clonogenic survival of 12V-H-ras transformed rat fibroblasts in response to cisplatin 2000 ·APOPTOSIS ·Kristina Viktorsson, T Heiden, Mikael Molin, Göran Akusjärvi, Stig Linder, (unknown)	8
18	ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation 1999 ·Clinical & Experimental Metastasis ·Maria Seddighzadeh, Jian‐Nian Zhou, Ulrike Kronenwett, Maria C. Shoshan, Gert Auer, Margareta Sten-Linder, Björn Wiman, Stig Linder	36
19	Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas 1997 ·Breast Cancer Research and Treatment ·(unknown), Georg Engel, Gert Auer, Hans Strander, Stig Linder	9
20	Induction of the collagenase phorbol ester response element by staurosporine 1994 ·Journal of Cellular Biochemistry ·Maria C. Shoshan, Stig Linder	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact